Abstract
Gabapentin is an important advancement for the treatment of neuropathic pain. This novel anticonvulsant has demonstrated efficacy and safety in multiple clinical trials. Its pharmacological properties especially lack of adverse effects on any major organ systems including cardiovascular and respiratory systems allows flexible titration in a wide range of patients. Certainly, there are many side effects but majority are manageable and all of them are reversible.
Keywords: neuropathic pain, gabapentin, dosing schedule, adverse events, side effects, efficacy
Current Neuropharmacology
Title: Symptomatic Treatment of Chronic Neuropathic Pain with Gabapentin Clinical Practice and Research Prospective
Volume: 1 Issue: 3
Author(s): Misha-Miroslav Backonja
Affiliation:
Keywords: neuropathic pain, gabapentin, dosing schedule, adverse events, side effects, efficacy
Abstract: Gabapentin is an important advancement for the treatment of neuropathic pain. This novel anticonvulsant has demonstrated efficacy and safety in multiple clinical trials. Its pharmacological properties especially lack of adverse effects on any major organ systems including cardiovascular and respiratory systems allows flexible titration in a wide range of patients. Certainly, there are many side effects but majority are manageable and all of them are reversible.
Export Options
About this article
Cite this article as:
Backonja Misha-Miroslav, Symptomatic Treatment of Chronic Neuropathic Pain with Gabapentin Clinical Practice and Research Prospective, Current Neuropharmacology 2003; 1 (3) . https://dx.doi.org/10.2174/1570159033477062
DOI https://dx.doi.org/10.2174/1570159033477062 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Disorders of Protein Biogenesis and Stability
Protein & Peptide Letters Effect of the Surfactant and Liquid Lipid Type in the Physico-chemical Characteristics of Beeswax-based Nanostructured Lipid Carrier (NLC) of Metformin
Pharmaceutical Nanotechnology Synthesis and Biological Evaluation of Novel 2,3-disubstituted Benzofuran Analogues of GABA as Neurotropic Agents
Medicinal Chemistry Restless Legs Syndrome in Multiple Sclerosis
CNS & Neurological Disorders - Drug Targets Basic Pharmacology of NMDA Receptors
Current Pharmaceutical Design Ubiquitin-Protein Ligases - Novel Therapeutic Targets?
Current Protein & Peptide Science Mouse Models of Genomic Syndromes as Tools for Understanding the Basis of Complex Traits: An Example with the Smith-Magenis and the Potocki-Lupski Syndromes
Current Genomics PredCSF: An Integrated Feature-Based Approach for Predicting Conotoxin Superfamily
Protein & Peptide Letters Bis-dihydroisoxazolines: Synthesis, Structural Elucidation, Antimicrobial Evaluation, and DNA Photocleavage Assay
Current Organic Synthesis Diagnostic Biomarkers of Epilepsy
Current Pharmaceutical Biotechnology Ketamine: New Indications for an Old Drug
Current Drug Targets The Interplay Among Epilepsy, Parkinson’s Disease and Inflammation: Revisiting the Link through Ca<sup>2+</sup>/cAMP Signalling
Current Neurovascular Research Current Overview of Inorganic Nanoparticles for the Treatment of Central Nervous System (CNS) Diseases
Current Nanomaterials The Need to Avoid the Routine Use of Episiotomy
Current Women`s Health Reviews Neurotoxic and Neuroactive Compounds from Cnidaria: Five Decades of Research….and More
Central Nervous System Agents in Medicinal Chemistry From Genomic Imprinting to Developmental Physiology: Identifying Stepping Stones
Current Pharmacogenomics Repetitive Transcranial Magnetic Stimulation (rTMS) to Treat Refractory Panic Disorder Patient: A Case Report
CNS & Neurological Disorders - Drug Targets Neuronal High-Affinity Sodium-Dependent Glutamate Transporters (EAATs): Targets for the Development of Novel Therapeutics Against Neurodegenerative Diseases
Current Pharmaceutical Design An Update on GABA Analogs for CNS Drug Discovery
Recent Patents on CNS Drug Discovery (Discontinued) Genome-wide Membrane Protein Structure Prediction
Current Genomics